Dr. Brandon DeKosky earned a Ph.D. in Biochemical Engineering from the University of Texas at Austin in 2015 and completed a Post Doc in Immunology & Vaccinology at the Vaccine Research Center, National Institute of Allergy and Infectious Diseases in Bethesda, MD in 2017. His research primarily focuses on inventing and applying advanced NextGen molecular biology techniques to accelerate development of new human vaccines and therapeutics.
Dr. Prajnaparamita Dhar (Prajna) received her Ph.D. in Physical Chemistry from Florida State University, spent some time in the laboratory of Dr. Joseph Zasadzinski at the University of California, Santa Barbara as a postdoctoral fellowship, after which she began her position at KU. Her research primarily focuses on understanding nature’s rules that govern biological self-assembled processes, in order to better mimic nature and design new treatments for various diseases.
Dr. Hardwidge earned his Ph.D. at the Mayo Clinic Graduate School. His research focuses on understanding, treating, and preventing diarrheal disease caused by bacterial pathogens by studying several virotypes of Escherichia coli that cause diarrhea and malnutrition in humans and livestock, including E. coli O157:H7, non-O157 STEC, and enterotoxigenic E. coli (ETEC). These pathogens, as well as other enteric bacteria that use contact-dependent secretion systems, represent important threats to food safety, biosecurity, and animal health.
Professor Picking earned her PhD at the University of Kansas. She most recently served as an associate professor at Oklahoma State University. Her research interests are vaccine development - especially for the children of low income countries, Enteric bacterial pathogens, and type III secretion.
Dr. Vikalp earned his PhD in Salmonella vaccine development from the School of Biotechnology, KIIT University - Bhubaneswar, India. He completed his research in collaboration with ETH Zurich, Switzerland where he worked in the lab of Prof. Wolf Dietrich Hardt. His research interest includes identification of virulence factors and development of mucosal vaccine strains against enteric bacterial pathogens. He is currently working on in vivo screening and validation of recombinant subunit vaccines for Shigellosis and Salmonellosis.
Graduate Research Assistants
Olivia Arizmendi received her BSc in Biomedical Research from the National Autonomous University of Mexico (UNAM). She is a PhD candidate in the Molecular Biosciences program. Her current projects encompass cell biology and protein-protein interactions.